14th PCNE Working Conference

Foppe van Mil was a co-founder of the Pharmaceutical Care Network Europe (PCNE) and since its establishment in 1994 the leading person of the association either as chair or professional secretary. He was dedicated to strengthening pharmaceutical care research and practice, always committed to innovation for the well-being of patients and public health. He was a researcher, teacher, networker, editor and last but not least a practicing community pharmacist. Major contributions are the development of the PCNE classification of DRPs, the definition of pharmaceutical care and the development of a typology for pharmacist-led medication reviews.

Since 2009 at each PCNE conference medication review was an important topic. Specific aspects were discussed and refined in dedicated workshops, most of them chaired or co-chaired by Foppe.

Today, medication review is seen as the cornerstone of pharmaceutical care. But still strong evidence of the impact of pharmacist-led medication review is lacking.
In the first part of this lecture important advancements and gaps were discussed with reference to Foppe van Mil.

In a second part, Anna Bollinger (PhD candidate in the Pharmaceutical Care Research Group of the University of Basel) presents the experiences of an observational case series study, in which PGx panel testing was applied to enrich medication reviews in patients with DRPs or therapy failure. PGx panel testing is a promising approach to identify the patient’s susceptibility to DRP reactively and to provide recommendations for future treatment decisions preemptively, both to ensure a safe and effective pharmacotherapy.

Breaks will be served in the Foyer Seminarraum (in front of the workshop room)

Pharmacy practice research often focuses on the design, implementation and evaluation of pharmacy services and interventions. This lecture highlights the importance of using theory to underpin pharmacy practice research to maximise its quality and impact and tries to clarify how such theoretical lenses can be used, selected, and applied correctly.

Breaks will be served in the Foyer Seminarraum (in front of the workshop room)

Breaks will be served in the Foyer Seminarraum (in front of the workshop room)

This lecture will provide an overview of recent developments in artificial intelligence (AI) within the field of pharmacy, highlighting how key AI techniques are driving related solutions in healthcare, with an emphasis on pharmacy practice. Challenges and opportunities related to implementation of these solutions into real-world settings will be discussed, with consideration on future implications for pharmaceutical care and evolving scope of practice. The lecture will also cover current trends in pharmacy practice related AI research, drawing on insights from editorial experience with submissions and publications in leading pharmacy journals.

Breaks will be served in the Foyer Seminarraum (in front of the workshop room)

Breaks will be served in the Foyer Seminarraum (in front of the workshop room)

Collaborative medication management reviews are now well established as a core component of pharmaceutical care in many countries around the world. Pharmacists providing collaborative medication management reviews can receive remuneration for providing services which aim to achieve the quality use of medicines. These services usually require interprofessional collaboration with primary care physicians, who make referrals to pharmacists to review complex regimens. Although most would agree that collaborative medication management review services are both efficacious and effective, a few contend that they are not. Complex health interventions require a sophisticated and comprehensive evaluation strategy – often beyond the scope of a single study. This presentation will discuss some of the key considerations in the evaluation of collaborative medication management review services and the strengths and weaknesses of various approaches, from resolution of medication related problems to quality of life and avoidance of hospitalisations. Factors which can lead to heterogeneity of findings will also be discussed, such as extent of interprofessional collaboration, experience of the pharmacist, and facilitators and barriers within the health care system, amongst others.

Breaks will be served in the Foyer Seminarraum (in front of the workshop room)